Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 17 |
| Apr 2026 | 0 | 8 |
| May 2026 | 0 | 9 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 9 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2021 Filed Nov 19, 2021 23:16 UTC |
SMITH SANDFORD DDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $9.45 | $0.00 |
DisclosureSEC source: 0001061983-21-000261 · edgardoc.xml · derivative · entry 7 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2028-05-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 23:16 UTC |
SMITH SANDFORD DDirector
|
SaleCommon Stock | 4,032 | $41.21 | $166,140.17 |
DisclosureSEC source: 0001061983-21-000261 · edgardoc.xml · nonDerivative · entry 6 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,765 F1 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 23:16 UTC |
SMITH SANDFORD DDirector
|
Exercise / conversionCommon Stock | 4,032 | $12.40 | $49,996.80 |
DisclosureSEC source: 0001061983-21-000261 · edgardoc.xml · nonDerivative · entry 5 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 23:16 UTC |
SMITH SANDFORD DDirector
|
SaleCommon Stock | 20,000 | $41.21 | $824,108.00 |
DisclosureSEC source: 0001061983-21-000261 · edgardoc.xml · nonDerivative · entry 4 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,765 F1 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 23:16 UTC |
SMITH SANDFORD DDirector
|
Exercise / conversionCommon Stock | 20,000 | $14.25 | $285,000.00 |
DisclosureSEC source: 0001061983-21-000261 · edgardoc.xml · nonDerivative · entry 3 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 23:16 UTC |
SMITH SANDFORD DDirector
|
SaleCommon Stock | 5,000 | $41.21 | $206,027.00 |
DisclosureSEC source: 0001061983-21-000261 · edgardoc.xml · nonDerivative · entry 2 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,765 F1 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 19, 2021 Filed Nov 19, 2021 23:16 UTC |
SMITH SANDFORD DDirector
|
Exercise / conversionCommon Stock | 5,000 | $9.45 | $47,250.00 |
DisclosureSEC source: 0001061983-21-000261 · edgardoc.xml · nonDerivative · entry 1 SMITH SANDFORD D · CIK 0001243004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 12, 2021 Filed Nov 12, 2021 22:23 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 4,143 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000259 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,143 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| November 12, 2021 Filed Nov 12, 2021 22:23 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 4,143 | $39.63 | $164,172.18 |
DisclosureSEC source: 0001061983-21-000259 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,063 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| November 12, 2021 Filed Nov 12, 2021 22:23 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 4,143 | $6.00 | $24,858.00 |
DisclosureSEC source: 0001061983-21-000259 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 364,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| November 11, 2021 Filed Nov 12, 2021 22:19 UTC |
Malik Fady IbrahamEVP Research & Development
|
SaleCommon Stock | 2,000 | $39.56 | $79,120.00 |
DisclosureSEC source: 0001061983-21-000257 · edgardoc.xml · nonDerivative · entry 1 Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,878 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F2 · balance_after: Includes 2,000 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:35 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 24,519 | $0.00 Strike: $9.65 | $0.00 |
DisclosureSEC source: 0001061983-21-000255 · edgardoc.xml · derivative · entry 6 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,519 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:35 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 20,481 | $0.00 Strike: $9.65 | $0.00 |
DisclosureSEC source: 0001061983-21-000255 · edgardoc.xml · derivative · entry 5 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,481 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:35 UTC |
Cragg DavidChief HR & Admin Officer
|
SaleCommon Stock | 20,481 | $41.76 | $855,290.66 |
DisclosureSEC source: 0001061983-21-000255 · edgardoc.xml · nonDerivative · entry 4 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,704 F1 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:35 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionCommon Stock | 20,481 | $9.65 | $197,641.65 |
DisclosureSEC source: 0001061983-21-000255 · edgardoc.xml · nonDerivative · entry 3 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:35 UTC |
Cragg DavidChief HR & Admin Officer
|
SaleCommon Stock | 24,519 | $41.76 | $1,023,918.34 |
DisclosureSEC source: 0001061983-21-000255 · edgardoc.xml · nonDerivative · entry 2 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,704 F1 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| November 09, 2021 Filed Nov 9, 2021 22:35 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionCommon Stock | 24,519 | $9.65 | $236,608.35 |
DisclosureSEC source: 0001061983-21-000255 · edgardoc.xml · nonDerivative · entry 1 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 22:23 UTC |
GAGE L PATRICKDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,166 | $0.00 Strike: $5.46 | $0.00 |
DisclosureSEC source: 0001061983-21-000253 · edgardoc.xml · derivative · entry 7 GAGE L PATRICK · CIK 0001196903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,166 shares Expires 2022-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 22:23 UTC |
GAGE L PATRICKDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 22,302 | $0.00 Strike: $4.02 | $0.00 |
DisclosureSEC source: 0001061983-21-000253 · edgardoc.xml · derivative · entry 6 GAGE L PATRICK · CIK 0001196903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,302 shares Expires 2023-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 22:23 UTC |
GAGE L PATRICKDirector
|
SaleCommon Stock | 4,166 | $41.33 | $172,196.61 |
DisclosureSEC source: 0001061983-21-000253 · edgardoc.xml · nonDerivative · entry 4 GAGE L PATRICK · CIK 0001196903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,932 F1 · balance_after: Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 22:23 UTC |
GAGE L PATRICKDirector
|
Exercise / conversionCommon Stock | 4,166 | $5.46 | $22,746.36 |
DisclosureSEC source: 0001061983-21-000253 · edgardoc.xml · nonDerivative · entry 3 GAGE L PATRICK · CIK 0001196903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 22:23 UTC |
GAGE L PATRICKDirector
|
SaleCommon Stock | 22,302 | $41.33 | $921,826.41 |
DisclosureSEC source: 0001061983-21-000253 · edgardoc.xml · nonDerivative · entry 2 GAGE L PATRICK · CIK 0001196903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,932 F1 · balance_after: Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 08, 2021 Filed Nov 8, 2021 22:23 UTC |
GAGE L PATRICKDirector
|
Exercise / conversionCommon Stock | 22,302 | $4.02 | $89,654.04 |
DisclosureSEC source: 0001061983-21-000253 · edgardoc.xml · nonDerivative · entry 1 GAGE L PATRICK · CIK 0001196903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Amount includes 3,128 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $14.25 | $0.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · derivative · entry 12 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2027-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,032 | $0.00 Strike: $12.40 | $0.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · derivative · entry 11 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,032 shares Expires 2027-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 2,798 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · derivative · entry 10 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,798 shares Expires 2023-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,166 | $0.00 Strike: $6.78 | $0.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · derivative · entry 9 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,166 shares Expires 2023-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 2,798 | $40.00 | $111,920.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 8 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 2,798 | $6.84 | $19,138.32 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 7 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 4,166 | $40.00 | $166,640.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 6 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 4,166 | $6.78 | $28,245.48 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 5 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 4,032 | $40.00 | $161,280.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 4 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 4,032 | $12.40 | $49,996.80 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 3 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 20,000 | $40.00 | $800,000.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 2 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionCommon Stock | 20,000 | $14.25 | $285,000.00 |
DisclosureSEC source: 0001061983-21-000250 · edgardoc.xml · nonDerivative · entry 1 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,503 | $0.00 Strike: $5.88 | $0.00 |
DisclosureSEC source: 0001061983-21-000251 · edgardoc.xml · derivative · entry 4 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,503 shares Expires 2022-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
HENDERSON JOHN TDirector
|
SaleCommon Stock | 8,503 | $40.00 | $340,120.00 |
DisclosureSEC source: 0001061983-21-000251 · edgardoc.xml · nonDerivative · entry 2 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,255 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. F2 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:33 UTC |
HENDERSON JOHN TDirector
|
Exercise / conversionCommon Stock | 8,503 | $5.88 | $49,997.64 |
DisclosureSEC source: 0001061983-21-000251 · edgardoc.xml · nonDerivative · entry 1 HENDERSON JOHN T · CIK 0001226488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. F2 · balance_after: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:16 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,675 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000247 · edgardoc.xml · derivative · entry 6 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,675 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:16 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 18,325 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000247 · edgardoc.xml · derivative · entry 5 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,325 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:16 UTC |
Cragg DavidChief HR & Admin Officer
|
SaleCommon Stock | 18,325 | $34.89 | $639,351.92 |
DisclosureSEC source: 0001061983-21-000247 · edgardoc.xml · nonDerivative · entry 4 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,704 F1 · security: Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021. F3 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:16 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionCommon Stock | 18,325 | $6.00 | $109,950.00 |
DisclosureSEC source: 0001061983-21-000247 · edgardoc.xml · nonDerivative · entry 3 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021. F3 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:16 UTC |
Cragg DavidChief HR & Admin Officer
|
SaleCommon Stock | 6,675 | $34.89 | $232,888.08 |
DisclosureSEC source: 0001061983-21-000247 · edgardoc.xml · nonDerivative · entry 2 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,704 F1 · security: Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021. F3 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:16 UTC |
Cragg DavidChief HR & Admin Officer
|
Exercise / conversionCommon Stock | 6,675 | $6.00 | $40,050.00 |
DisclosureSEC source: 0001061983-21-000247 · edgardoc.xml · nonDerivative · entry 1 Cragg David · CIK 0001316459 · Chief HR & Admin Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Amount of securities beneficially owned following reported transaction has been adjusted by 1,541 shares purchased pursuant to ESPP but were not previously reported. Reporting persons Form 4 filed on 10/1/2021 erroneously stated that the reported 137,123 shares owned following reporting persons transaction on October 1, 2021 included 13,678 shares of common stock purchased pursuant to ESPP, but in fact only 12,137 shares of common stock purchased pursuant to ESPP were included in that 137,123 share total. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2021. F3 · balance_after: Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:16 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000246 · edgardoc.xml · derivative · entry 5 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 5,000 shares Expires 2023-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:16 UTC |
Blum Robert IDirector · President & CEO
|
SaleCommon Stock | 5,000 | $35.80 | $178,996.50 |
DisclosureSEC source: 0001061983-21-000246 · edgardoc.xml · nonDerivative · entry 2 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,063 F1 · security: Amount of securities beneficially owned following reported transaction has been adjusted by 2500 shares representing shares owned by reporting person as a stockholder of record on August 26, 2013, which has previously not been included prior Form 4s as a result of a reporting error. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F3 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:16 UTC |
Blum Robert IDirector · President & CEO
|
Exercise / conversionCommon Stock | 5,000 | $6.00 | $30,000.00 |
DisclosureSEC source: 0001061983-21-000246 · edgardoc.xml · nonDerivative · entry 1 Blum Robert I · CIK 0001288859 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Amount of securities beneficially owned following reported transaction has been adjusted by 2500 shares representing shares owned by reporting person as a stockholder of record on August 26, 2013, which has previously not been included prior Form 4s as a result of a reporting error. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020. F3 · balance_after: Includes 5,695 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 19, 2021 Filed Oct 20, 2021 22:56 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,999 | $0.00 Strike: $6.84 | $0.00 |
DisclosureSEC source: 0001061983-21-000240 · edgardoc.xml · derivative · entry 6 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,798 Underlying: Common Stock · 1,999 shares Expires 2023-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| October 19, 2021 Filed Oct 20, 2021 22:56 UTC |
PARSHALL B LYNNEDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,333 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001061983-21-000240 · edgardoc.xml · derivative · entry 5 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,333 shares Expires 2023-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
| October 19, 2021 Filed Oct 20, 2021 22:56 UTC |
PARSHALL B LYNNEDirector
|
SaleCommon Stock | 8,333 | $35.73 | $297,773.92 |
DisclosureSEC source: 0001061983-21-000240 · edgardoc.xml · nonDerivative · entry 4 PARSHALL B LYNNE · CIK 0001073385 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.